Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 5: Risk factors associated with hemorrhagic complications
Odds Ratio 95% Wald CI P Value
Sex 0.640 0.205–1.994 .441
Age 1.013 0.965–1.063 .613
Hypertension 0.549 0.179–1.679 .293
Smoking 1.138 0.385–3.363 .814
Previous stroke/TIA 0.600 0.129–2.796 .516
Dyslipidemia 0.800 0.233–2.744 .722
Prior antithrombotic usage 0.978 0.244–3.928 .975
Aneurysm presentation 
 Unruptured, symptomatic 0.380 0.039–3.726 .406
 Recurrent or residual 1.187 0.345–4.081 .786
Aneurysm location (posterior circulation) 1.755 0.525–5.864 .361
Aneurysm morphology (fusiform) 0.592 0.060–5.840 .654
Aneurysm size 0.989 0.904–1.083 .812
Antiplatelet medication (ticagrelor) 0.669 0.230–1.946 .461
Treatment technique (flow-diverter) 0.948 0.297–3.025 .929

	Odds Ratio	95% Wald CI	P Value
Sex	0.640	0.205–1.994	.441
Age	1.013	0.965–1.063	.613
Hypertension	0.549	0.179–1.679	.293
Smoking	1.138	0.385–3.363	.814
Previous stroke/TIA	0.600	0.129–2.796	.516
Dyslipidemia	0.800	0.233–2.744	.722
Prior antithrombotic usage	0.978	0.244–3.928	.975
Aneurysm presentation
Unruptured, symptomatic	0.380	0.039–3.726	.406
Recurrent or residual	1.187	0.345–4.081	.786
Aneurysm location (posterior circulation)	1.755	0.525–5.864	.361
Aneurysm morphology (fusiform)	0.592	0.060–5.840	.654
Aneurysm size	0.989	0.904–1.083	.812
Antiplatelet medication (ticagrelor)	0.669	0.230–1.946	.461
Treatment technique (flow-diverter)	0.948	0.297–3.025	.929